BW
LH icon

Basepoint Wealth’s Labcorp LH Stock Holding History

Basepoint Wealth’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$54.9K Sell
206
-34
-14% -$9.21K 0.03% 204
2025
Q4 		$60.4K Buy
+240
New +$63.7K 0.04% 190
2024
Q1 		– Sell
-1,101
Closed -$250K – 118
2023
Q4 		$250K Sell
1,101
-53
-5% -$11.1K 0.2% 88
2023
Q3 		$232K Sell
1,154
-185
-14% -$39K 0.19% 91
2023
Q2 		$278K Buy
1,339
+4
+0.3% +$776 0.23% 84
2023
Q1 		$263K Sell
1,335
-59
-4% -$12.1K 0.22% 87
2022
Q4 		$282K Buy
+1,394
New +$272K 0.25% 78

Other funds holding LH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Basepoint Wealth's LH Position: Q1 2026 in Review

Basepoint Wealth reduced its Labcorp (LH) stake by 14% in Q1 2026, selling an estimated $9.21K and leaving 206 shares worth $54.9K. The position accounts for 0.03% of the portfolio, ranked #204.

Basepoint Wealth first reported a position in LH in Q4 2022 and has held it in 7 quarters since. The position peaked at $282K in Q4 2022. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Basepoint Wealth held 206 shares of Labcorp worth $54.9K as of Q1 2026.
  • Basepoint Wealth sold 34 Labcorp shares in Q1 2026, an estimated $9.21K.
  • Labcorp made up 0.03% of Basepoint Wealth's portfolio in Q1 2026, its #204 holding.
  • Basepoint Wealth first reported a position in Labcorp in Q4 2022 and has held it in 7 quarters since.
  • Basepoint Wealth's Labcorp position peaked at $282K in Q4 2022.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Basepoint Wealth's 13F filing for Q1 2026, filed 7 May 2026.